Harald Burchardt

Harald Burchardt's work experience begins in 2009 with a 6-month placement as a Working Student at Rohde & Schwarz, where they completed their Master of Science thesis and filed a granted patent for a shortwave multicast data link protocol.

From 2013 to 2015, Harald worked at pureLiFi Ltd, initially as a Communication Systems Engineer involved in product specification and development planning. Harald later took on roles as Director of Product Management and Chief Operating Officer, contributing to company strategy, key decision-making, and the funding process. Harald served as Chief Commercial Officer and Director on the Board of Directors until November 2019.

In 2017, Harald joined Liver Health UK as a Director on the Board of Directors, focusing on company and product strategy, investment fundraising, and the success of the LivOn! brand.

In 2020, Harald became the Chief Operating Officer of Rehamed Therapy, and in 2021, they transitioned to the role of Head of Finance at Yodawy.

Harald Burchardt pursued their educational journey in a systematic and progressive manner. Starting in 2004, they obtained a Bachelor of Science (BSc) degree in Electrical Engineering and Computer Science from Jacobs University Bremen. This foundation led him to further their studies, and from 2007 to 2009, they attended the Technical University of Munich, where they obtained a Master of Science (MSc) degree in Communications Engineering. Eager to deepen their expertise, Harald then joined The University of Edinburgh from 2010 to 2013 to achieve a Doctor of Philosophy (PhD) degree in Digital Communications. Throughout their education history, Harald consistently focused on developing their knowledge and skills in the field of communications and digital technology.